In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Photoshop tutorial showing how to make natural-looking sunbeams filtering through forest trees. Canada's Carney fires back at Trump after Davos speech Latest weather forecast for dangerous, massive US ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly. News headlines Recursion Pharmaceuticals (RXRX) faces challenges with a 58% share ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Discover how Merkle roots ensure data integrity in blockchain transactions and reduce verification time. Learn their role in ...

What is loneliness and why do we feel it? Sophie and Neil discuss how feeling lonely can help us to survive ...